๐ฐ French Commercial Code News
Page 33 - French Commercial Code News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from French Commercial Code. Real-time updates on events, politics, business and more.
July 25, 2023
PRESS RELEASE Lyon, July 25, 2023 ADOCIA announces Q2 2023 financial results and a โฌ10 million financing operation ...
July 21, 2023
Disclosure of the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the French Commercial Code and the Article 223-16...
July 19, 2023
Biophytis / Key word(s): Financing Biophytis Announces $3.8 Million Registered Direct Offering 19-Jul-2023 / 07:5...
July 18, 2023
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French...
July 12, 2023
12 July 2023 Orange: information on the total number of shares and voting rights referred to in Article L.233-8 II of the French Commercial Code and...
July 12, 2023
SOCIETE GENERALE: Number of shares composing current share capital and Total number of voting rights as of 30/06/2023Regulated Information Paris, 12 July...
July 12, 2023
12.07.2023 - SOCIETE GENERALE: Number of shares composing current share capital and Total number of voting rights as of 30/06/2023Regulated Information Paris, 12 July 2023 Information about the total number of voting rights and shares pursuant to Article ...
July 11, 2023
Dawn raids: the First President of the Paris Court of Appeal orders the destruction and return of mailboxes delivered by a company, whose premises had been searched, after the closure...
July 7, 2023
07.07.2023 - Regulatory News: Issuer Corporate name SEB S.A. (Paris:SK) Registered office 112 Chemin du Moulin Carron, 69130 Ecully- France Stockmarket Euronext Paris - A ISIN FR0000121709 Numbers of shares and voting rights : ย 31 May 2023 30 June 2023 Shares ...
July 6, 2023
Article 223-16 of the General Regulations of the Financial Markets Authority (AMF - Autorité des Marchés Financiers)LYON, France--(BUSINESS WIRE)--$MAAT--Regulatory News:MaaT Pharma (EURONEXT: MAAT โ the โCompanyโ), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem Therap...